# Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis)

> **NCT01134705** · PHASE3 · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 474 (actual)

## Conditions studied

- Rhinitis, Allergic, Perennial

## Interventions

- **DRUG:** Beclomethasone dipropionate hydrofluoroalkane HFA Nasal Aerosol
- **DRUG:** Placebo Nasal Aerosol

## Key facts

- **NCT ID:** NCT01134705
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 474 (ACTUAL)
- **Last updated:** 2012-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01134705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01134705, "Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01134705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*